Serena Williams targets US Open return amid medication scrutiny

Serena Williams is preparing for a return to professional tennis following a recent injury setback. After being forced to withdraw from a scheduled doubles match with her sister, Venus Williams, at Wimbledon due to a knee injury, the 23-time Grand Slam champion has signaled her intention to compete in the upcoming US Open in New York.

Alongside her athletic recovery, Williams continues to face public scrutiny regarding her use of GLP-1 medications for weight management. Advertisements for the company RO, for which Williams serves as an ambassador, were prominently displayed during the Cincinnati Open. While Williams has defended her use of such medication as a medically backed decision to manage her weight following childbirth, the campaign has drawn criticism from fans who have previously viewed her as a champion of body image.